$TSOI in the lawsuit and amicus brief filed by CEO Tim Dixon, clearly states that JADICELLS LLC, RESTEM LLC, and the University of Miami (collectively referred to as "the TRIO") seriously messed up the data in the clinical FDA phase 2a/2b trial and somehow managed to get FDA approval. In February 2021, JADICELLS LLC sold its IP and the clinical 2a/2b JADICELLS trial to $TSOI. However, $TSOI later discovered that the TRIO had used some other inferior cells to pass the phase 2a/2b approval, committing a massive fraud on the FDA. It is in this context that $TSOI brought the lawsuit and amicus brief to light, seeking punishment for the TRIO. Talk about a cellular-level screw-up!

Chartmaster lets ride $TSOI to multiple cents

Chartmaster, good to see you load up on timely loading of $TSOI .it's like the little OTC engine that could, chugging its way up the charts – except this train doesn't stop until it's in cents range this time around.

$TSOI 🌶️ Who would've thought that a mix of broccoli, pterostilbene, green tea, and a dash of METFORMIN could have patent attorneys scratching their heads? Looks like the joke's on you, skeptics – time to eat your words with a side of humble pie.

$TSOI In a groundbreaking recent study (https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/cbf.3956), it's been revealed that Pterostilbene is abona fide oxidative stress slayer! 🦸‍♀️ With powers beyond compare, it fearlessly tackles H2O2-induced oxidative stress all while casually regulating GAS6/Axl signaling in HL-1 cells. Now that's what I call multitasking! 💪

So, whether you're battling free radicals or just need a superhero sidekick for your daily wellness routine, remember the name: Pterostilbene - the unsung hero of cellular defense, and the shining star of #quadramune by $TSOI! 🌟

As a proud shareholder of $TSOI, I find myself marveling at the ongoing saga of lawsuits being launched against the nefarious keyboard warriors lurking on Yahoo Finance, Stocktwits, and Twitter. It's like watching a legal drama unfold in the digital wild west!

But let's not underestimate the power of these legal maneuvers. Taking a stand against the bad and paid posters is not just about clearing the air, it's about staking our claim to credibility in the market. After all, nothing says "serious business" like a lawsuit or two, right?

Now, while TSOI is flexing its legal muscles, as a shareholder, I've got my eye on the prize. Quadramune and Nanostilbene sales need to start, gaining leaps and bounds with every step. And let's not forget about those dividend distribution and Phase 3 trials for Campbell Neuro Sciences Inc - it's high time they completed their grand performance!

Looking ahead, I've got my calendar marked for August 2024, eagerly awaiting the kickoff of multiple Phase 3 trials to tackle ARDS and COPD. Let's get those trials rolling and keep up the legal jousting and the scientific conquests - we're all rooting for $TSOI to shine brighter than a supernova!

$TSOI will $10 million be enough to fund an ARDS clinical phase 3 trial? Well, if we're comparing apples to elephants, it might seem like trying to fit a circus tent into a suitcase! With recent trials clocking in at a whopping $117 million, it's like trying to budget for a gourmet feast with just a handful of loose change. if there's a will, there's a way—and with TSOI's subsidiaries churning out their own JADICELLS at ALLOGEN BIOLOGICS, we might just be able to pull off this biologic magic trick within that $10 million budget! It's like trying to build a skyscraper with LEGO bricks—improbable, perhaps, but not entirely impossible!

$TSOI investors diving into series B preferred shares aren't just blindly jumping into Series B funding—they're fully aware that JADICELLS are far superior than Sabizabulin from $VERU, Ruxolitinib from $INCY, Extracellular Vesicle from Direct Biologics, LLC, and EB05 from $EDSA— It's like comparing a sleek sports car to a rusty old bicycle—there's just no competition! So, buckle up, investors, because we're about to take this ARDS treatment race to warp speed with JADICELLS leading the charge!

$TSOI's pulling a financial rabbit out of its hat, raising a cool $10 million cash in what they call 'near term non-dilutive' fashion, all thanks to 5% of those projected ARDS Phase 3 post-BLA revenues! 👍👏👏👏 Talk about turning medical miracles into money-makers! It's like hitting the jackpot at a magic-themed casino—except instead of pulling rabbits out of hats, we're pulling in cash from groundbreaking clinical trials! Series B 5% funding to fuel Phase 3?

$TSOI Sure If was high net worth individual , i would have bet my dollars, I wouldn't miss the chance to snag myself a cozy 5% slice of those sweet, sweet ARDS treatment revenues once that phase 3 clinical trial is successful and the BLA is in the bag!

$TSOI it seems like investors are blowing their horns louder than a marching band at halftime about $TSOI's tech prowess in their biotech lab! With over 80 patent applications, they've practically got a patent portfolio thicker than a phonebook (remember those?). But hold your horses, folks, because despite the releasing over 180 PRs since 2020, the market's not exactly rewarding the effort with the stock price sliding from 17 cents to 0.001! It's like bringing a kazoo to a symphony orchestra—sure, it's fun, but we're all waiting for the big crescendo of revenues, phase 3 trials, and partnerships with leading labs to really hit the high notes!

$TSOI is taking on Big Pharma like a lone ranger armed with nothing but patents and stem cells! Talk about a David vs. Goliath showdown. Who needs a slingshot when you've got natural remedies and a knack for saving lives without those side effects, right? But apparently, the market missed the memo and decided to give $TSOI's stock price a rollercoaster ride from 17 cents to 0.001! Somebody needs to tell the market that TSOI isn't just playing with test tubes and pipettes—they're pioneering the future of biologic drugs! Here's to hoping the market wakes up from its nap and realizes that TSOI isn't just a small fish—it's a potential big fish in the pond of innovation! 🐟💼 #PatentPower #MarketSnooze

I believe You can reach out to $TSOI timdixon@tsoimail.com and submit your information to get qualified and then proceed accordingly

$TSOI's Series B% Preferred stock is the golden ticket of the stock market, promising adventures beyond chocolate dreams. Instead of Oompa Loompas, it's funding Phase 3 ARDS – talk about a factory of possibilities! Five percent of potential future revenues? That's sweeter than finding a golden goose laying golden eggs.

$TSOI Alright, folks, gather 'round! It seems like our treatments at VIAB are so exclusive, they come with a 'priceless' label... literally! $TSOI is not about to let those pesky price tags stand in the way of bringing JADICELLS and STEMVACS to the masses. It's time for us to don our negotiation hats and play a round of 'Insurance Roulette.' Because let's face it, getting insurance companies to pay up is like convincing a cat to take a bath—it's going to take some serious convincing and probably a few scratches along the way. But hey, $TSOI is up for the challenge! After all, who doesn't love a good underdog story with a sprinkle of insurance bureaucracy?

$TSOI Remember, when it comes to stocking up on stem cells for our JADICELLS and STEMVACS, think 'girl power'! Apparently, the female stem cells are like the Wonder Women of the cell world—multiplying and saving the day. Sorry, fellas, it's just science... and maybe a dash of girl magic!

Waiting for that dividend letter from $TSOI's subsidiary, Campbell Sciences, feels like waiting for a letter from Hogwarts – except instead of a wizardry school, it's a magical payout. I hope the legal stuff doesn't turn it into a snail mail marathon.I am hanging in there, maybe it's just waiting for the perfect moment!

$TSOI it's like playing a game of stock trading Tetris. lets say you snag 2600 of those sweet 5% dividend Series B shares. Now, fast forward to a future where $TSOI common shares hit lets hope $20 a pop. It's like hitting the jackpot at the stock market casino! Your 2600 Series B shares transform into 1300 TSOI common shares faster than you can say "buy low, sell high!" It's like trading in two slightly worn sneakers for a fresh pair of kicks, but with stocks instead!

$TSOI so now that's the game plan! $TSOI is raising a cool $10 million using their fancy 5% Series B convertible preferred shares. But here's the kicker - they're doing it with all the finesse of a master illusionist. Only a measly 5% annual dilution, kind of like sneaking a few extra sprinkles on your ice cream cone without anyone noticing. And get this, until the share price hits $10, it's like they're keeping the dilution on a tight leash, like a magician's assistant with a secret trapdoor. So, fear not, fellow investors, it looks like $TSOI is pulling off financial feats without making our portfolios disappear into thin air!

Looks like $TSOI is going for the "bigger is better" approach! On February 20, 2024, they decided that their stock cupboard wasn't quite big enough and decided to expand it. They're increasing their Authorized Shares from 5.5 billion to a whopping 6.5 billion shares! That's like going from a regular-sized pizza to a pizza the size of a football field. And hey, they're also throwing in an extra 5 million shares of Preferred Stock, because who doesn't love a little extra topping on their pizza, right? Now we just need to figure out what they plan to do with all those extra slices...

$TSOI management is eagerly awaiting the Judge's verdict on whether to consider the CEO's amicus brief in the appellate court (case #23-2054, Restem, LLC v. Jadi Cell, LLC). $TSOI has already provided key information on the alleged wrongdoings by both parties involved in the case. But if the Judge decides to ignore the points mentioned in the Amicus Brief submitted by $TSOI, it could turn into yet another comedy of errors in this legal saga!

$TSOI stock – it's like waiting for a snail to finish a marathon!Maybe FINRA will send a telegram or the FDA will unveil a surprise party for pending INDs.maybe even TSOI's subsidiaries will throw us a curveball and announce a licensing deal!

$CBIA i have a feelling has strong chance to hit 30 cents

just imagine $CBIA soaring to 30 cents like it's on a rocket fueled by espresso, all because it's aiming to be the $SBUX Starbucks of vending machines! Forget just regular coffee – we're talking about a future where your vending machine can whip up a caramel macchiato with a flick of its AI-powered wrist! Who knew caffeinated dreams could be so lucrative?

$CBIA for a generational ride from 0.0012 to 30 cents faster than you can say 'venti mocha frappuccino'! It's like poor man's Starbucks on steroids, we'll have a robot barista taking orders and serving up 'wake and bake' blends at every corner in North America!

$TSOI With the present Outstanding Shares standing at 3.9 billion, it seems like $TSOI is setting sail with a formidable fleet. As a curious shareholder, I'm eager to grasp the helm of understanding regarding the company's plans, especially across its NINE subsidiaries.

Any insights into capex on 10 million funding from GHS Inc. details, would not only satiate our curiosity but also empower us with a clearer vision of the exciting direction $TSOI is poised to take.

Tim Your leadership is pivotal in steering the ship, and I have full confidence on you and $TSOI is in a prime position to execute its plans with finesse.

Your commitment to keeping shareholders informed is genuinely valued, and I believe this transparency will fortify the bond between the company and its investors.

$CBIA has all the momentum to go to multiple pennies with all good things happening from the company

$TSOI LONGS have been waiting for dividends longer than it takes to rain in a desert! Maybe once those dividends hit, it'll be raining money in their trading accounts, and suddenly, Wall Street will be all, "$TSOI who?" But until then, it's like trying to explain why socks disappear in the laundry—mysterious and frustrating! Blaming the PPS slide on unexpected lawsuits, dwindling sales of QM and NS, and the FDA taking longer than a sloth in rush hour traffic—it's like TSOI is playing a game of financial whack-a-mole! Let's hope they get those INDs approved before we see flying pigs on Wall Street!

You might want to check out $TSOI, which is currently trading at an incredibly low market cap despite having multiple FDA clinical phase 3 trials underway. They've even announced dividends in one of their nine privately held subsidiaries, with plans to do the same for others. With promising pipeline success in phase 3 trials, $TSOI could see significant growth potential, possibly reaching multiple dollars in value.

You might want to check out $TSOI, which is currently trading at an incredibly low market cap despite having multiple FDA clinical phase 3 trials underway. They've even announced dividends in one of their nine privately held subsidiaries, with plans to do the same for others. With promising pipeline success in phase 3 trials, $TSOI could see significant growth potential, possibly reaching multiple dollars in value.

$CBIA is revving its engines like a penny stock on a mission! With a jaw-dropping 581 million common share return, it's like they're making it rain shares. Pink current status is next on their checklist. It's like waiting for the next season of your favorite show. We've got the inside scoop on $CBIA's Pepsi distribution partnership, and let me tell you, it's fizz-tastic! Rumor has it, they're about to make waves in the beverage industry. And as if that's not enough to wet your whistle, big-name beverage companies are eyeing $CBIA like it's the last cold drink in the desert. It's like being the popular kid at school - everyone wants a piece of the action!

Let me retract my comment immediately and rush to do my homework on imaginary reserves. Thanks for the enlightenment!

Hogwarts ! because nothing screams credibility like a casual mention of a $10 million reserve, right?

$TSOI It's reassuring to know that TSOI has a $10 million reserve to pursue those responsible for the drastic drop in its stock price from 17 cents to 0.0012 since February 2021. TSOI's legal action will establish a precedent, not just in OTC markets but also in NASDAQ and NYSE exchanges, sending a clear message and penalizing all involved parties.

Received dividend of 2% in BTCFX and 10% in BTCLX

$AMLH pulled in 13K wagering today..Hmm....

$CBIA Step 1: Spot .005+...check. Step 2: Wait for .01+...check. Step 3: Prepare snacks for the long haul because we're aiming for 03+...check. Step 4: Start considering early retirement plans at 05+...check. Step 5: Call the yacht dealer because we've hit .30+! Just remember to invite me to the maiden voyage.😅😂😅😂😅😂😅😂😅😂😅😂😅😂😅😂

$CBIA $420,000 wagered in $CBIA today...That HUGE in OTC..possibly heading to 30 cents for sure

"Breaking news: $CBIA's filing for pink status is in, folks! It's like getting upgraded from black-and-white TV to Technicolor! And hold onto your hats because we're about to dive into the world of #BTC payment processing with $NYAX - it's the crypto equivalent of finding buried treasure! And as for the distribution partnership with PepsiCo? Forget about 'cola wars,' we're talking about 'cola alliances' now! Stay tuned for more updates, and don't forget to stock up on $CBIA

$CBIA forget even reaching silver! we might be on the verge of a fortune bigger than Elon Musk's dreams of colonizing Mars!